# Chart Review of Patients Undergoing Ketamine Infusions

> **NCT04209296** · — · COMPLETED · sponsor: **Brain and Cognition Discovery Foundation** · enrollment: 891 (actual)

## Conditions studied

- Major Depressive Disorder
- Bipolar Disorder
- Obsessive-Compulsive Disorder
- Post Traumatic Stress Disorder

## Interventions

- **DRUG:** Ketamine Hydrochloride

## Key facts

- **NCT ID:** NCT04209296
- **Lead sponsor:** Brain and Cognition Discovery Foundation
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-03
- **Primary completion:** 2023-09-14
- **Final completion:** 2023-09-14
- **Target enrollment:** 891 (ACTUAL)
- **Last updated:** 2024-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04209296

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04209296, "Chart Review of Patients Undergoing Ketamine Infusions". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04209296. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*